fluoxymesterone has been researched along with Dysmyelopoietic Syndromes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauters, F; Cambier, N; Caulier, MT; Fenaux, P; Sautière, D; Wattel, E | 1 |
Baumelou, E; Calvo, F; Casassus, P; Chomienne, C; Ciccone, F; Degos, L; Fenaux, P; Gris, JC; Najean, Y; Thomas, G | 1 |
1 review(s) available for fluoxymesterone and Dysmyelopoietic Syndromes
Article | Year |
---|---|
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature.
Topics: Aged; Cell Differentiation; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Fluoxymesterone; Humans; Middle Aged; Myelodysplastic Syndromes | 1987 |
2 trial(s) available for fluoxymesterone and Dysmyelopoietic Syndromes
Article | Year |
---|---|
Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases.
Topics: Adult; Aged; Aged, 80 and over; Danazol; Female; Fluoxymesterone; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Pilot Projects; Platelet Count; Thrombocytopenia | 1994 |
Present results of the treatment of myelodysplastic syndromes with low-dose cytosine arabinoside. Preliminary results of a cooperative protocol (38 patients) and review of the literature.
Topics: Aged; Cell Differentiation; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Fluoxymesterone; Humans; Middle Aged; Myelodysplastic Syndromes | 1987 |